Introduction Antidepressants are widely used for the pharmacological treatment of anxiety
and mood disorders. Since the eruption of the SARS-COV-2 pandemic and the later …

ABSTRACT Background Direct oral anticoagulants (DOACs) may be involved in drug–drug
interactions (DDIs) potentially increasing the risk of adverse drug reactions. This study …

Introduction: The oral antiviral agents nirmatrelvir-ritonavir (NMV/r) and molnupiravir are
used to treat mild-to-moderate COVID-19 infection in outpatients. However, the use of NMV/r …

What is known and objective: Antiretrovirals have a high drug interaction potential, which
can lead to increased toxicity and/or decreased efficacy. Multiple databases are available to …

Background and Objectives: Patients with schizophrenia are often exposed to
polypharmacotherapy, which may lead to drug—drug interactions. The aim of the study was …

What is known and objective Patients who have undergone haematopoietic stem cell
transplantation are prone to drug–drug interactions due to polypharmacy. Drug–drug …

Background Drug-drug interactions (DDIs) are factors of adverse drug reactions and are
more common in elderly patients. Identifying potential DDIs can prevent the related risks …

As more drugs are developed and the incidence of polypharmacy increases, it is becoming
critically important to anticipate potential DDIs before they occur in the clinic, along with …

Clinicians caring for persons with mental illness should be aware of increased mortality,
physical problems, and health disparities in this population. This article provides a brief …

Abstract Nirmatrelvir-ritonavir (NMV/r) and molnupiravir are used to treat mild-to-moderate
COVID-19 infection in outpatients. However, the use of NMV/r is complicated by clinically …